Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

VIDEO: Calabrese talks difficult-to-treat inflammatory disease

Дата публикации: 22-09-2026 09:30:00

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage examining the persistence of difficult-to-treat immune-mediated inflammatory disease in the biologic era.“I think we’re taking a more holistic and realistic approach to these patients,” Calabrese said. “And we have some world experts weighing in on several high-impact publications just within the past 6 months.”Calabrese additionally discussed coverage from the Rheumatology Nurses Society Annual Conference regarding integrative

Основное содержимое страницы с новостью.

healio rheumatology logo

September 22, 2026

1 min watch

healio rheumatology logo

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Added to email alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights recent coverage examining the persistence of difficult-to-treat immune-mediated inflammatory disease in the biologic era.

“I think we’re taking a more holistic and realistic approach to these patients,” Calabrese said. “And we have some world experts weighing in on several high-impact publications just within the past 6 months.”

Calabrese additionally discussed coverage from the Rheumatology Nurses Society Annual Conference regarding integrative medicine, particularly the use of herbs and supplements alongside traditional medicine.

“We also have some great coverage from RNS on integrative immunology, and the role of chamomile, perhaps, in improving quality of life,” he said.

For more information:

Leonard H. Calabrese, DO, can be reached at calabrl@ccf.org or at rheumatology@healio.com.

Published by: healio rheumatology logo

Sources/Disclosures Source:

Healio Interview

Disclosures: Calabrese reports being a medical advisor for OpenEvidence, as well as professional relationships with AbbVie, AstraZeneca, Bristol Myers Squibb, Galvani, Genentech, GlaxoSmithKline, Janssen, Novartis, Regeneron, Sanofi and UCB.

Healio AI

Ask a clinical question and tap into Healio AI's knowledge base.

  • PubMed, enrolling/recruiting trials, guidelines
  • Clinical Guidance, Healio CME, FDA news
  • Healio's exclusive daily news coverage of clinical data

Read more about

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Added to email alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1A new era for difficult immune-mediated inflammatory diseases011.0621-09-2026
2‘Pain is a real disease’: Treating chronic pain requires multidisciplinary approach08.1824-09-2026
3Hooked on Rheum with Brittany Hill, DO08.1416-09-2026
4‘Think critically’: Caution key in assessing clinical trial data07.7319-09-2026
5Speaker: CAR T-cell trial deaths add ‘sobriety’ to discussions with autoimmune patients09.1728-09-2026
6Speaker: GLP-1s may be anti-inflammatory ‘even without obesity’010.6120-09-2026
7SetPoint System ‘increasing its effectiveness over time’ in RA07.8118-09-2026
8FDA fast tracks Yutrepia for Raynaud’s phenomenon in SSc08.4617-09-2026
9Newly discovered inflammatory cell signaling could open the door to autoimmune disease treatments010.8123-09-2026
10Ученые связали трудноизлечимый артрит с депрессией и нарушениями сна07.5328-09-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 12.58. Источник: www.healio.com.